Valeo Financial Advisors, LLC Bluebird Bio, Inc. Transaction History

Valeo Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$18.04 - $22.09 $51,017 - $62,470	-2,828 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$16.59 - $33.89 $4,811 - $9,828	290 Added 11.43%	2,828 $85,000
Q4 2020 Feb 11, 2021	BUY	$27.5 - $37.92 $68,750 - $94,800	2,500 Added 6578.95%	2,538 $110,000
Q3 2020 Oct 28, 2020	SELL	$34.44 - $43.75 $68 - $87	-2 Reduced 5.0%	38 $2,000
Q2 2020 Jul 20, 2020	BUY	$27.12 - $45.97 $54 - $91	2 Added 5.26%	40 $2,000
Q1 2020 Apr 13, 2020	SELL	$26.16 - $63.5 $1,621 - $3,937	-62 Reduced 62.0%	38 $2,000
Q2 2018 Aug 14, 2018	BUY	$99.64 - $127.59 $9,964 - $12,759	100 New	100 $16,000

20.2M

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $305M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.